| Target Price | CN¥66.21 |
| Price | CN¥28.87 |
| Potential |
129.33%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Shanghai Haohai Biological-h 2027 .
The average Shanghai Haohai Biological-h target price is CN¥66.21.
This is
129.33%
register free of charge
CN¥68.16
136.08%
register free of charge
CN¥65.56
127.08%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Shanghai Haohai Biological-h to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Shanghai Haohai Biological-h stock has an average upside potential 2027 of
129.33%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CN¥ | 2.47 | 2.91 |
| 8.33% | 17.59% | |
| EBITDA Margin | 17.04% | 25.25% |
| 16.21% | 48.21% | |
| Net Margin | 10.15% | 19.16% |
| 34.88% | 88.77% |
2 Analysts have issued a sales forecast Shanghai Haohai Biological-h 2026 . The average Shanghai Haohai Biological-h sales estimate is
This results in the following potential growth metrics:
2 Shanghai Haohai Biological-h Analysts have issued a net profit forecast 2026. The average Shanghai Haohai Biological-h net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CN¥ | 1.08 | 2.44 |
| 40.00% | 125.93% | |
| P/E | 11.88 | |
| EV/Sales | 1.42 |
2 Analysts have issued a Shanghai Haohai Biological-h forecast for earnings per share. The average Shanghai Haohai Biological-h EPS is
This results in the following potential growth metrics and future valuations:
Shanghai Haohai Biological-h...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


